M. Potter

H. Goldschmidt, H. Einsele, J. Johansson, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune reconstitution after BMT in children.

M. Potter, T. Wallington, J. Cornish, 1993, Bone marrow transplantation.

The Role of Itraconazole in Preventing and Treating Systemic Fungal Infections in Immunocompromised Patients

M. Potter, J. Donnelly, 2004, Acta Haematologica.

Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality.

G. Morgan, D. Cunningham, F. Dignan, 2006, The Journal of hospital infection.

Mycobacterium tuberculosis infection following allogeneic peripheral blood stem cell transplantation

I. Kerridge, H. Prentice, M. Potter, 2003, Internal medicine journal.

Bone marrow transplantation for autoimmune diseases

A. Berger, M. Potter, C. Black, 1999, BMJ.

A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation

N. Russell, J. Byrne, H. Prentice, 2006, Bone Marrow Transplantation.

Agranulocytosis caused by dapsone therapy for granuloma annulare.

M. Potter, C. Kennedy, R. Slade, 1989, Journal of the American Academy of Dermatology.

Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study.

M. Potter, T. Wigmore, P. Gruber, 2012, British journal of anaesthesia.

Granulocyte-macrophage colony-stimulating factor (GM-CSF), hypocalcemia, and hypomagnesemia.

M. Potter, A. Oakhill, M. Mott, 1990, Annals of internal medicine.

Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole

M. Potter, V. Bigley, R. Gosling, 2004, Bone Marrow Transplantation.

Fatal invasive cerebral Absidia corymbifera infection following bone marrow transplantation

H. Prentice, B. Shaw, M. Potter, 2000, Bone Marrow Transplantation.

Platelet concentrates irradiated with ultraviolet light retain satisfactory in vitro storage characteristics and in vivo survival

M. Potter, I. Fraser, M. Meenaghan, 1990, British journal of haematology.

Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants.

S. Grace, J. Madrigal, P. Travers, 2001, The Journal of infectious diseases.

Title : Recipient / Donor HLA and CMV matching in recipients of T cell depleted 1 unrelated donor haematopoietic cell transplants 2 3 4 Short title : Donor factors in transplant outcome 5 6

S. Mackinnon, J. Madrigal, A. Clark, 2016 .

A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.

C. Sabin, A. Burroughs, P. Griffiths, 2004, The Journal of infectious diseases.

Transient erythroblastopenia of childhood with CD10, TdT, and cytoplasmic mu lymphocyte positivity in bone marrow.

M. Potter, T. Wallington, A. Oakhill, 1990, Journal of clinical pathology.

The study of minimal residual disease in acute lymphoblastic leukaemia

M. Potter, N. Goulden, K. Langlands, 1995, Clinical molecular pathology.

Minimal residual disease analysis for the prediction of relapse in children with standard‐risk acute lymphoblastic leukaemia

J. Hancock, M. Potter, N. Goulden, 1998, British journal of haematology.

The use of the polymerase chain reaction to detect minimal residual disease in childhood acute lymphoblastic leukaemia.

M. Potter, N. Goulden, A. Oakhill, 1993, European journal of cancer.

Wintrobe's clinical hematology, Vol. 1 and 2. G. Richard Lee, John Foerster, John Lukens, Frixos Paraskevas, John P. Greer and George M. Rodgers (Eds). Williams & Wilkins. 1998. Price: ?120.00. ISBN: 0 683 18242 0

M. Potter, 1999 .

PCR of Gene Rearrangements for the Detection of Minimal Residual Disease in Childhood ALL.

M. Potter, N. Goulden, K. Langlands, 1996, Methods in molecular medicine.

Clonal instability in early B-lineage acute lymphoblastic leukemia.

M. Potter, A. Oakhill, C. Steward, 1992, Blood.

Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

J. Briones, N. Russell, R. Malladi, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

M. Potter, P. Humphries, N. Goulden, 2011 .

P. Griffiths, H. Prentice, A. Clark, 1999, British journal of haematology.

Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors

N. Russell, S. Mackinnon, J. Madrigal, 2016, Haematologica.

UK experience of unrelated cord blood transplantation in paediatric patients

A. Gennery, J. Snowden, P. Veys, 2016, British journal of haematology.

Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission

C. Craddock, N. Russell, R. Clark, 2009, Haematologica.

Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience

G. Lucchini, P. Veys, A. Vora, 2015, Bone Marrow Transplantation.

C. Craddock, N. Russell, J. Byrne, 2011, British journal of haematology.

C. Craddock, N. Russell, J. Snowden, 2016, British journal of haematology.

Patient/Donor CMV Matching Is a Critical Determinant of Survival in Unrelated Donor Haematopoietic Stem Cell Transplantation

N. Russell, S. Mackinnon, J. Madrigal, 2014 .

Equality Of Access To Transplant For Ethnic Minority Patients Through Use Of Cord Blood and Haploidentical Transplants

C. Craddock, N. Russell, S. Mackinnon, 2013 .

The feasibility of plerixafor as a second-line stem cell mobilizing agent in children.

M. Potter, P. Anoop, M. Ethell, 2011, Journal of pediatric hematology/oncology.

Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT.

C. Craddock, M. Labopin, A. Nagler, 2016, The oncologist.

Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.

James Robinson, N. Russell, S. Mackinnon, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

(2019). Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study. Biology of Blood and Marrow Transplantation , 25 (3), 443-450.

N. Russell, S. Mackinnon, J. Madrigal, 2019 .

Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review.

J. V. van Dongen, C. Bartram, J. Goldman, 1993, Leukemia.

Long‐term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high‐dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments

G. Morgan, C. Dearden, F. Davies, 2005, British journal of haematology.

The use of defibrotide in the management of vascular endothelial complications (VOD/HUS/TTP) of stem cell transplantation.

H. Prentice, B. Shaw, M. Potter, 1999 .

Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver.

J. Delgado, A. Dhillon, S. Mackinnon, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative

C. Craddock, E. Tholouli, C. Crawley, 2020, Bone Marrow Transplantation.

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia

J. Esteve, N. Kröger, C. Craddock, 2015, Haematologica.

Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML

E. Tholouli, N. Russell, J. Byrne, 2020, Bone Marrow Transplantation.

Better HLA Matching as Revealed Only by Next Generation Sequencing Technology Results in Superior Overall Survival Post-Allogeneic Haematopoietic Cell Transplantation with Unrelated Donors

N. Russell, S. Mackinnon, J. Madrigal, 2018 .

RELAPSE OF PRIMITIVE MEDIASTINAL LYMPHOMA AS A MYELOID MASS FOLLOWING BEAM AUTOLOGOUS TRANSPLANT AND SUBSEQUENT REFRACTORINESS TO MATCHED UNRELATED UMBILICAL CORD BLOOD ALLOGRAFT

A. Wotherspoon, M. Potter, P. Anoop, 2009, Pediatric Hematology & Oncology.

The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study

J. Gribben, S. Mackinnon, D. Linch, 2008, Hematology.

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party

H. Einsele, R. Fanin, N. Kröger, 2016, Leukemia.

Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT

M. Labopin, J. Finke, A. Nagler, 2017, Oncotarget.

Impact of detectable measurable residual disease on umbilical cord blood transplantation

J. Sierra, F. Baron, M. Labopin, 2020, American journal of hematology.

Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients

B. Shaw, M. Potter, R. Raobaikady, 2015, Thrombosis Journal.

Identification of non-naïve CD4+CD45RA+ T cell subsets in adult allogeneic haematopoietic cell transplant recipients

H. Prentice, M. Potter, P. Travers, 2003, Bone Marrow Transplantation.

Survival and outcome of blastoid variant myeloma following treatment with the novel thalidomide containing regime DT‐PACE

G. Morgan, M. Jenner, F. Davies, 2008, European journal of haematology.

The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide – vincristine – doxorubicin – methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysis

G. Morgan, M. Jenner, F. Davies, 2006, Leukemia & lymphoma.

Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R‐GEM‐P) is an effective regimen in relapsed diffuse large B‐cell lymphoma

M. Gleeson, A. Horwich, A. Wotherspoon, 2015, European journal of haematology.

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

J. Hancock, J. Cornish, M. Potter, 1998, British journal of haematology.

Is Stem Cell Transplantation for Transformed Follicular Lymphoma Required in the Rituximab Era?: The Royal Marsden Experience 2003-2013

M. Gleeson, A. Horwich, A. Wotherspoon, 2014 .

First report of fatal human infections with the cactophilic yeast Sporopachydermia cereana.

G. Morgan, M. Potter, Elizabeth M. Johnson, 2011, The Journal of infection.

GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma

A. Horwich, A. Wotherspoon, D. Cunningham, 2014, Annals of Hematology.

Sequence of two new HLA-Cw alleles: HLA-Cw*0313 and HLA-Cw*1208.

A. Little, J. Madrigal, M. Potter, 2002, Tissue antigens.

Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy.

A. MacGowan, M. Potter, D. Reeves, 1990, The Journal of antimicrobial chemotherapy.

Influenza A andthevirus associated haemophagocytic syndrome: Cluster ofthree cases inchildren withacuteleukaemia

M. Potter, A. Oakhill, 1991 .

Eosinophilic leukaemia with an abnormality of 5q31, the site of the IL-5 gene.

M. Potter, P. Yates, 2008, Clinical and Laboratory Haematology.

Adjuvant use of GM-CSF in invasive aspergillosis.

H. Prentice, M. Potter, C. Kibbler, 1998 .

Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party

H. Einsele, N. Kröger, I. Yakoub-Agha, 2021, Bone Marrow Transplantation.

Autologous Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT

S. Montoto, H. Goldschmidt, H. Einsele, 2016 .

T-Cell Depleted Unrelated Donor Stem Cell Transplants Appear to Be of Value for Adult Philadelphia Chromosome Negative ALL Patients and Should Be Evaluated Prospectively in New Large Group Studies

C. Craddock, N. Russell, R. Clark, 2008 .

Comparison of RIC-alloHCT and autoHCT for > 55 years old patients with acute lymphoblastic leukemia: an analysis from Acute Leukemia Working Party of the EBMT

M. Labopin, A. Nagler, M. Mohty, 2015 .

Lack of association of the heparanase gene single-nucleotide polymorphism Arg307Lys with acute lymphoblastic leukaemia in patients from Northern Ireland

G. Morgan, M. Potter, M. Ethell, 2008 .

Trends in Autologous Transplantation for Myeloma in EBMT Centres between 1993 and 2017

J. Gribben, H. Goldschmidt, I. Yakoub-Agha, 2019, Blood.

Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD

J. Scarisbrick, C. Crawley, J. Cavenagh, 2014, Bone Marrow Transplantation.

Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML

F. Dignan, B. Shaw, M. Potter, 2014, Bone Marrow Transplantation.

Improving the outcome of unrelated donor stem cell transplantation by molecular matching.

J. Madrigal, B. Shaw, M. Potter, 2001, Blood reviews.

Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation.

J. Bodmer, B. Shaw, M. Potter, 2004, Tissue antigens.

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD

G. Mufti, J. Scarisbrick, J. Cavenagh, 2012, Bone Marrow Transplantation.

European experience with oral solution and intravenous itraconazole.

M. Potter, 2001, Oncology.